Follow Us
is404()): ?>

Sorry! We can't find that video.

But you may be interested in the videos below.

Terms of Use Privacy Policy

Here’s Why AstraZeneca Is Worth $98.7B to Pfizer

April 28 (Bloomberg) -- Bloomberg’s Olivia Sterns examines Pfizer’s renewed bid for AstraZeneca in what would be a $98.7 billion deal on Bloomberg Television’s “In The Loop.”

Source: Bloomberg

Top Trending Videos